Search research articles
Contact Us
Filters
Showing results (121-130 of 666) with videos related to
Page
of 67
Sort By:
Child Psychiatry and Human Development
|
November 2, 2013
Hyperkinetic syndrome: The role of depression
J P Zrull, J F McDermott, E Poznanski
Nature Reviews. Rheumatology
|
February 29, 2020
Moving towards a systems-based classification of innate immune-mediated diseases
Sinisa Savic, Emily A Caseley, Michael F McDermott
Journal of the American Academy of Child and Adolescent Psychiatry
|
October 1, 2013
The Journal at the Academy's Sixtieth Anniversary
John F McDermott, Mina K Dulcan, Andrés Martin
Cancer
|
May 9, 2025
The emerging role of lymphocyte-activation gene 3 targeting in the treatment of solid malignancies
Vinay K Giri, David F McDermott, Jacob Zaemes
Expert Review of Anticancer Therapy
|
June 14, 2022
Tivozanib in relapsed or refractory advanced renal cell carcinoma: a focus on US approval
Hollis Viray, David F McDermott, David J Einstein
Immunological Reviews
|
May 13, 1999
The MHC big bang
L Abi Rached, M F McDermott, P Pontarotti
Cancer Journal (Sudbury, Mass.)
|
January 24, 2017
Clinical Trial Design and Endpoints for Stage IV Melanoma in the Modern Era
Benjamin Izar, Meredith M Regan, David F McDermott
Trends in Pharmacological Sciences
|
April 26, 2018
ER Stress: A Therapeutic Target in Rheumatoid Arthritis?
Marveh Rahmati, Mohammad Amin Moosavi, Michael F McDermott
Journal of the American Academy of Child and Adolescent Psychiatry
|
September 1, 1990
A study of the Board Certification Examination in Child and Adolescent Psychiatry
P E Tanguay, J F McDermott, I Philips
Joint Bone Spine
|
April 5, 2011
Is caspase 1 central to activation of interleukin-1?
Miriam Wittmann, Sarah R Kingsbury, Michael F McDermott
Page
of 67
Search research articles
Search
Showing results (121-130 of 666) with videos related to
Sort By:
Page
of 67
Child Psychiatry and Human Development
|
November 2, 2013
Hyperkinetic syndrome: The role of depression
J P Zrull, J F McDermott, E Poznanski
Nature Reviews. Rheumatology
|
February 29, 2020
Moving towards a systems-based classification of innate immune-mediated diseases
Sinisa Savic, Emily A Caseley, Michael F McDermott
Journal of the American Academy of Child and Adolescent Psychiatry
|
October 1, 2013
The Journal at the Academy's Sixtieth Anniversary
John F McDermott, Mina K Dulcan, Andrés Martin
Cancer
|
May 9, 2025
The emerging role of lymphocyte-activation gene 3 targeting in the treatment of solid malignancies
Vinay K Giri, David F McDermott, Jacob Zaemes
Expert Review of Anticancer Therapy
|
June 14, 2022
Tivozanib in relapsed or refractory advanced renal cell carcinoma: a focus on US approval
Hollis Viray, David F McDermott, David J Einstein
Immunological Reviews
|
May 13, 1999
The MHC big bang
L Abi Rached, M F McDermott, P Pontarotti
Cancer Journal (Sudbury, Mass.)
|
January 24, 2017
Clinical Trial Design and Endpoints for Stage IV Melanoma in the Modern Era
Benjamin Izar, Meredith M Regan, David F McDermott
Trends in Pharmacological Sciences
|
April 26, 2018
ER Stress: A Therapeutic Target in Rheumatoid Arthritis?
Marveh Rahmati, Mohammad Amin Moosavi, Michael F McDermott
Journal of the American Academy of Child and Adolescent Psychiatry
|
September 1, 1990
A study of the Board Certification Examination in Child and Adolescent Psychiatry
P E Tanguay, J F McDermott, I Philips
Joint Bone Spine
|
April 5, 2011
Is caspase 1 central to activation of interleukin-1?
Miriam Wittmann, Sarah R Kingsbury, Michael F McDermott
Page
of 67